European urothelial carcinoma market is estimated to grow significantly at a CAGR of around 9.2%, during the forecast period. The growth of the market is attributed to well-developed healthcare infrastructure, significant healthcare expenditure, and growing prevalence and incidence of urothelial carcinoma across many European economies. Sedentary lifestyle such as smoking, consumption of drugs, and alcohol in European countries are the major factors for the growing incidence of urothelial carcinoma among men and women in the region. The government’s initiatives, programs, and funding for cancer-related programs are further contributing to the growth of the urothelial carcinoma market in the region. The report includes an analysis of the European urothelial carcinoma market based on the major countries, UK, Germany, France, Spain, Italy, and Rest of Europe (RoE). Among these countries, RoE holds a significant share due to the incidence rate of urothelial carcinoma in Denmark, Netherlands, Sweden, and Belgium.
European urothelial carcinoma market is segmented into diagnosis and treatment. Based on the diagnosis, the market is segmented into cystoscopy, biopsy, urinalysis, urine cytology, intravenous pyelogram (IVP), and others. Based on treatment, the market is segmented into chemotherapy, immunotherapy, radiation therapy, surgery, and other treatment which include targeted therapy. Cystoscopy is one of the most common and primary procedures used in the diagnosis of urothelial carcinoma. The procedure confers low risk during the diagnosis and permits urologist to take biopsy samples and resect papillary tumors during cystoscopy. Among treatment procedures, chemotherapy is highly adopted as it kills cancer cells that are spread to other parts of the body, far from its primary tumor.
OMR Global Recently Published Report on: https://www.omrglobal.com/industry-reports/european-urothelial-carcinoma-market
Market Segmentation
European Urothelial Carcinoma Market by Diagnosis
- Cystoscopy
- Biopsy
- Urinalysis
- Urine Cytology
- Intravenous Pyelogram (IVP)
- Others (Biomarkers)
European Urothelial Carcinoma Market by Treatment
- Surgery
- Chemotherapy
- Immunotherapy
- Radiation Therapy
- Others (Targeted Therapy)
To Learn More About this Report Request a Free Sample Copy @ https://www.omrglobal.com/request-sample/european-urothelial-carcinoma-market
This release has been published on OMR Industry Journal. OMR Industry Journal is not responsible for any content included in this release.
